Openshaw M R

6PUBLICATIONS
26CO-AUTHORS
Tumour immunologyCancer diagnosisHaematological tumoursMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 05, 2024
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study.

David J Pinato, Antonio D'Alessio, Claudia Angela Maria Fulgenzi

|Apr 27, 2023
Taxonomic reclassification of Kaposi Sarcoma identifies disease entities with distinct immunopathogenesis.

M R Openshaw, E Gervasi, C A M Fulgenzi

|Aug 26, 2022
Mismatch Repair Screening of Gastrointestinal Cancers: The Impact on Lynch Syndrome Detection and Immunotherapy.

Openshaw M R, Williams J, Foo T

|Apr 09, 2022
Sensitive screening of single nucleotide polymorphisms in cell free DNA for diagnosis of gestational tumours.

Geoffrey J Maher, Rosemary A Fisher, Baljeet Kaur

|Mar 27, 2021
Back from the Brink: EGFR Inhibition in Gastroesophageal Cancer.

Mark R Openshaw, David J Pinato, Nicola Valeri

|Jul 29, 2020
Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma.

Mark R Openshaw, Ali Abdulnabi Suwaidan, Barbara Ottolini

Pageof 1